EFFICACY AND SAFETY OF USTEKINUMAB FOR ULCERATIVE COLITIS THROUGH 4 YEARS: FINAL RESULTS FROM THE UNIFI LONG-TERM EXTENSION

Waqqas Afif  ¹     Maria T. Abreu  ²     Silvio Danese  ³     William Sandborn  ⁴     Ye Miao  ⁵     Hongyan Zhang  ⁵     Remo Panaccione  ⁶     Tadakazu Hisamatsu  ⁷     Ellen J. Scherl  ⁸     Rupert W Leong  ⁹     David Rowbotham  ¹⁰     Ramesh P. Arasaradnam  ¹¹     Laurent Peyrin-Biroulet  ¹²     Bruce E. Sands  ¹³     Colleen W. Marano  ^13    
1 McGill University Health Center, Montreal, Canada
² University of Miami, Miller School of Medicine, Miami, United States
³ Vita-Salute San Raffaele University - IRCCS San Raffaele Scientific Institute, Milan, Italy
⁴ University of California San Diego, San Diego, United States
⁵ Janssen Research & Development, LLC, Spring House
⁶ University of Calgary, Calgary, Canada
⁷ Kyorin University School of Medicine, Tokyo, Japan
⁸ Weill Cornell Medicine, New York Presbyterian Hospital, New York, United States
⁹ Concord Hospital, Sydney, Australia
¹⁰ Auckland City Hospital, Auckland, New Zealand
¹¹ University Hospital Coventry and Warwickshire, Coventry Warwickshire, United Kingdom
¹² Nancy University Hospital, Vandoeuvre-les-Nancy, France
¹³ Icahn School of Medicine at Mount Sinai, New York, United States

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)